Accession Number: | 0000899243-21-009379 |
Date: | 2021-03-01 |
Issuer: | ITEOS THERAPEUTICS, INC. (ITOS) |
Original Submission Date: |
MCGRATH YVONNE
C/O ITEOS THERAPEUTICS, INC.
139 MAIN STREET
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 41.58 | 2021-03-01 | deemed execution date | A | 45,000 (a) | 2031-03-01 | common stock 45,000 | $41.58 | 45,000 | direct |
ID | footnote |
---|---|
f1 | this stock option shall vest over 4 years, with 25% vesting on march 1, 2022 and thereafter in equal monthly installments over the next 36 months subject to the reporting person's continued service to the issuer. |